These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9442496)

  • 41. First person account: meaning of psychoses.
    Murphy MA
    Schizophr Bull; 1997; 23(3):541-3. PubMed ID: 9327521
    [No Abstract]   [Full Text] [Related]  

  • 42. Life satisfaction among individuals with schizophrenia in the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Am J Psychiatry; 2013 Sep; 170(9):1061-2. PubMed ID: 24030617
    [No Abstract]   [Full Text] [Related]  

  • 43. Pitfalls in animal models.
    Cohen MR
    Arch Gen Psychiatry; 1991 Apr; 48(4):379-80. PubMed ID: 1672590
    [No Abstract]   [Full Text] [Related]  

  • 44. Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia.
    Dourish CT; Dawson GR
    Biomark Med; 2014; 8(1):5-8. PubMed ID: 24325219
    [No Abstract]   [Full Text] [Related]  

  • 45. First person account: falling on the pavement.
    Campbell T
    Schizophr Bull; 2000; 26(2):507-9. PubMed ID: 10885647
    [No Abstract]   [Full Text] [Related]  

  • 46. Risperidone for treatment of childhood schizophrenia.
    Sourander A
    Am J Psychiatry; 1997 Oct; 154(10):1476. PubMed ID: 9326842
    [No Abstract]   [Full Text] [Related]  

  • 47. The course and treatment of schizophrenia in later life.
    Ruskin PE; Nyman G
    Hosp Community Psychiatry; 1988 Sep; 39(9):929-30. PubMed ID: 2905692
    [No Abstract]   [Full Text] [Related]  

  • 48. Risperidone treatment of complex hallucinations in a patient with posterior cortical atrophy.
    Campbell JJ; Ngo G
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):378-9. PubMed ID: 18806250
    [No Abstract]   [Full Text] [Related]  

  • 49. Risperidone and related 5HT2/D2 antagonists: a new type of antipsychotic agent?
    Megens AA; Kennis LE
    Prog Med Chem; 1996; 33():185-232. PubMed ID: 8776944
    [No Abstract]   [Full Text] [Related]  

  • 50. Stuttering improved with risperidone.
    van Wattum PJ
    J Am Acad Child Adolesc Psychiatry; 2006 Feb; 45(2):133. PubMed ID: 16429082
    [No Abstract]   [Full Text] [Related]  

  • 51. [3 years of risperidone: from innovation to example].
    Nervenarzt; 1997 Apr; 68(4 Suppl Von Der In):1-4. PubMed ID: 9442496
    [No Abstract]   [Full Text] [Related]  

  • 52. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
    Yoshida K; Higuchi H; Hishikawa Y
    Clin Neuropharmacol; 1998; 21(1):68-9. PubMed ID: 9579290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Risperidone].
    Zolk O; Thürauf N
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
    Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Schizophrenia and quality of life--newly defined therapeutic targets].
    Psychiatr Prax; 1997 Nov; 24(6 Suppl Schizophre):1-4. PubMed ID: 9431365
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.